Pfizer established global drug development centre at IIT Madras Research Park

Pfizer has set up a global drug development centre at the IIT Madras Research Park in Chennai, India...

Bharat Biotech seeks DCGI nod for stage 2/3 Covaxin booster trial among two to 18-year-old

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI...

Aleor Dermaceuticals receives final USFDA approval for new cold sore drug

Alembic Pharmaceuticals Limited (Alembic) announced that its wholly-owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from...

Rezolute declares positive results from phase 2B RIZE study of RZ358 in patients with congenital hyperinsulinism

Rezolute, Inc., a clinical-stage biopharmaceutical company, announced positive results from its phase 2b RIZE study of RZ358 in patients with congenital hyperinsulinism (HI), which were unveiled in a late-breaking oral presentation at the Paediatric.

Aurobindo Pharma receives USFDA nod for generic cancer drug Bortezomib

Aurobindo Pharma on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator to manufacture and market its generic version of Bortezomib for injection used to treat certain types....

OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment

OSE Immunotherapeutics SA declared the grant of a new patent from the European Patent Office (EPO) strengthening the protection covering its novel myeloid cell immune checkpoint target, CLEC-1 (a C-type lectin receptor), and its use in cancer...

Biocytogen Pharma inks antibody agreement with Merck

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate Biocytogen’s proprietary antibodies against at least three distinct.

Ionova enters clinical trial partnership with Merck to evaluate INV-1120 in combo with Keytrudain patients with advanced solid tumours

Ionova Life Science Co., Ltd., a clinical-stage biotech company, announces it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Kenilworth, NJ., USA) to evaluate clinical benefits of INV-1120, Ionova’s EP4...

India's Pharma exports witnessed growth up to 103% since 2013-14

Indian pharma exports witnessed a growth of 103 per cent since 2013-14. A significant rise has been reported from Rs 90,415 crores in 2013-14 to Rs 1,83,422 crores in 2021-22, the Ministry of Commerce and Industry informed...

Sputnik Light to be specified as precaution dose for those vaccinated with Sputnik V

The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources...

© 2025 India Pharma Outlook. All Rights Reserved.